{"data":{"id":"us-tx/tex.-insurance-code-1369.654","jurisdiction":"us-tx","citation":"Tex. Insurance Code § 1369.654","heading":"PROHIBITION ON MULTIPLE PRIOR AUTHORIZATIONS.","body":"(a) A health benefit plan issuer that provides prescription drug benefits may not require an enrollee to receive more than one prior authorization annually of the prescription drug benefit for a prescription drug prescribed to treat an autoimmune disease, hemophilia, or Von Willebrand disease.\n(b) This section does not apply to:\n(1) opioids, benzodiazepines, barbiturates, or carisoprodol;\n(2) prescription drugs that have a typical treatment period of less than 12 months;\n(3) drugs that:\n(A) have a boxed warning assigned by the United States Food and Drug Administration for use; and\n(B) must have specific provider assessment; or\n(4) the use of a drug approved for use by the United States Food and Drug Administration in a manner other than the approved use.\nAdded by Acts 2023, 88th Leg., R.S., Ch. 669 (H.B. 755), Sec. 1, eff. September 1, 2023.","path":["INSURANCE CODE","TITLE 8. HEALTH INSURANCE AND OTHER HEALTH COVERAGES","SUBTITLE E. BENEFITS PAYABLE UNDER HEALTH COVERAGES","CHAPTER 1369. BENEFITS RELATED TO PRESCRIPTION DRUGS AND DEVICES AND RELATED SERVICES","SUBCHAPTER N. COVERAGE OF PRESCRIPTION DRUGS FOR AUTOIMMUNE DISEASES AND CERTAIN BLOOD DISORDERS"],"source_url":"https://statutes.capitol.texas.gov/Docs/IN/htm/IN.1369.htm#1369.654","current_through":"89th 2nd Called Legislative Session, 2025","vintage":"","retrieved_at":"2026-08-27T01:47:21Z","sha256":"d40749ab24caabfcbb588c0d3f4289e03d3ec9ee3ee5d27e078a80e42c11f031","source_id":"us-tx","stale":false,"prev":"us-tx/tex.-insurance-code-1369.653","next":"us-tx/tex.-insurance-code-1369.761"},"notice":"GroundRules: Original legal text. Not legal advice."}